Upregulation of SRSF3 was also associated with shorter overall survival in our dataset (p < 0.01, Fig. 1d) and in TCGA CRC dataset (p = 0.006, Fig. 1e). This evidence concerns the gene SRSF3 and colorectal carcinoma.